Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Summary

The purpose of this study is to determine the safety and efficacy of 4 mg of Ramelteon, once daily (QD), in subjects with chronic insomnia.

Timeline

Start

2007-08

Primary completion

2008-03

Completion

2008-03

Outcome

Met primary endpoint

registry analysis (superiority or other test); Placebo QD vs Ramelteon 4 mg QD; p <0.001; ANCOVA NCT00756002 ↗

Drugs

Indications